Loading dose of quinine in African children with cerebral malaria

Area of Science:

• Tropical Medicine
• Pediatric Infectious Diseases
• Malariology

Background:

• Cerebral malaria is a severe complication of Plasmodium falciparum infection, often leading to rapid mortality.
• Early and effective treatment is crucial, as many deaths occur within 48 hours of hospital admission.
• The standard treatment regimen for quinine may be insufficient in the critical early hours.

Purpose of the Study:

• To evaluate the impact of a quinine loading dose on clinical outcomes in children with cerebral malaria.
• To investigate the association between serum iron levels and mortality in pediatric cerebral malaria.
• To assess the effect of quinine loading dose on recovery time, parasite clearance, and fever resolution.

Main Methods:

• Retrospective review of clinical and laboratory data for 113 children diagnosed with cerebral malaria.
• Comparison of outcomes between children who received a standard quinine dose and those who received an initial loading dose (20 mg/kg) followed by maintenance doses (10 mg/kg every 8 hours).
• Analysis of serum iron levels, transferrin saturation, mortality, coma recovery, parasite clearance, fever duration, and hemoglobin levels.

Main Results:

• Elevated serum iron levels, indicated by transferrin saturation, were significantly associated with increased mortality.
• Children receiving a quinine loading dose demonstrated faster recovery from coma and more rapid clearance of parasitemia and fever.
• Trends suggested lower mortality and higher hemoglobin levels in the loading dose group, though these did not reach statistical significance.

Conclusions:

• A quinine loading dose appears beneficial for improving clinical recovery in pediatric cerebral malaria patients.
• High serum iron levels are a critical risk factor for mortality in cerebral malaria.
• Further prospective studies are warranted to confirm the mortality benefit of quinine loading doses in this population.